VTRVentas

Compare with peers → Embed

Filings with the SEC since Jul 16, 2019

1,008 filings, 16 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 6, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Oct 28, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Nov 10, 2026

8-K: Other events

Filed in the last 30 days

of 1,008 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 34 events

Nov 10, 20268-K Other events 8-K item 8.01
Oct 28, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 27, 20268-K Quarterly results 8-K item 2.02
Sep 15, 2026Officer CFO and CAO change (the “Company”) approved the appointment of Laurida Sayed as its Senior Vice President, Chief Accounting Officer and Controller of the Company, effective on or around October 5, 2026 (the “Effective Date”).
Jul 30, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Jul 29, 20268-K Quarterly results 8-K item 2.02
Jun 15, 20268-K Director or officer change, Other events 8-K items 5.02, 8.01
Jun 5, 2026Buy EMBLER MICHAEL J (Director) bought $197K open-market purchase on Jun 3, 2026
May 15, 2026Offering At-the-market program: up to $3.0B of common stock 424B5 · We refer to a Sales Agent, when acting as sales agent for the relevant Forward Purchaser, as individually, a “Forward Seller,” and collectively, the “Forward Sellers.” In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock from time to time through the
May 15, 20268-K Director or officer change, Shareholder vote results, Other events 8-K items 5.02, 5.07, 8.01
Apr 28, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Apr 27, 20268-K Quarterly results 8-K item 2.02
Feb 20, 2026Officer CAO change Probst will assume the responsibilities of Chief Accounting Officer on an interim basis while the Company conducts a comprehensive search for a permanent successor.
Feb 9, 2026Offering At-the-market program: up to $2.5B of common stock 424B5 · We refer to a Sales Agent, when acting as sales agent for the relevant Forward Purchaser, as individually, a “Forward Seller,” and collectively, the “Forward Sellers.” In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock from time to time through the
Feb 9, 20268-K Other events 8-K item 8.01
Feb 6, 202610-K Annual report (10-K) period ended Dec 31, 2025
Feb 5, 20268-K Quarterly results 8-K item 2.02
Jan 7, 20268-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
Dec 4, 20258-K Other events 8-K item 8.01
Nov 17, 2025Officer CEO change Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”).
Oct 30, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Oct 29, 20258-K Quarterly results 8-K item 2.02
Jul 31, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
Jul 30, 20258-K Quarterly results 8-K item 2.02
Jun 13, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · Shelf registered
Jun 13, 2025Offering At-the-market program: up to $2.2B of common stock 424B5 · We refer to a Sales Agent, when acting as sales agent for the relevant Forward Purchaser, as individually, a “Forward Seller,” and collectively, the “Forward Sellers.” In accordance with the terms of the Sales Agreement, we may offer and sell our common stock from time to time through the Sales Agen
Jun 13, 20258-K Other events 8-K item 8.01
Jun 3, 20258-K Other events 8-K item 8.01
May 15, 20258-K Shareholder rights changed, Bylaws or fiscal year changed, Shareholder vote results 8-K items 3.03, 5.03, 5.07
May 1, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Apr 30, 20258-K Material agreement signed, Quarterly results, New debt or obligation 8-K items 1.01, 2.02, 2.03
Feb 13, 202510-K Annual report (10-K) period ended Dec 31, 2024
Feb 12, 20258-K Quarterly results 8-K item 2.02
Nov 15, 20248-K Other events 8-K item 8.01

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1008 Annual & quarterly 31 Current reports (8-K) 84 Insiders 739 Proxy & votes 33 Big owners (13D/13G) 43 Shares & debt offered 41 SEC letters 8 Other 29

Filed	Form	What it is	Period
Apr 1, 2026	DEFA14A	Extra proxy material		all files
Apr 1, 2026	DEF 14A	Proxy statement	May 13, 2026	all files
Apr 16, 2025	DEFA14A	Extra proxy material		all files
Apr 1, 2025	DEFA14A	Extra proxy material		all files
Apr 1, 2025	DEF 14A	Proxy statement	May 13, 2025	all files
Mar 19, 2025	PRE 14A		Mar 19, 2025	all files
Apr 2, 2024	DEFA14A	Extra proxy material		all files
Apr 2, 2024	DEF 14A	Proxy statement	May 14, 2024	all files
Jan 12, 2024	DEFA14A	Extra proxy material		all files
Jan 11, 2024	DEFA14A	Extra proxy material		all files
Apr 5, 2023	DEFA14A	Extra proxy material		all files
Apr 5, 2023	DEF 14A	Proxy statement		all files
Apr 25, 2022	DEFA14A	Extra proxy material		all files
Apr 21, 2022	DEFA14A	Extra proxy material		all files
Apr 20, 2022	DEFA14A	Extra proxy material		all files
Apr 19, 2022	DEFA14A	Extra proxy material		all files
Apr 18, 2022	DEFA14A	Extra proxy material		all files
Apr 14, 2022	DEFA14A	Extra proxy material		all files
Apr 11, 2022	DEFA14A	Extra proxy material		all files
Apr 8, 2022	DEFA14A	Extra proxy material		all files
Apr 5, 2022	DEFA14A	Extra proxy material		all files
Mar 29, 2022	DEFA14A	Extra proxy material		all files
Mar 23, 2022	DEFA14A	Extra proxy material		all files
Mar 16, 2022	DEFA14A	Extra proxy material		all files
Mar 9, 2022	DEFA14A	Extra proxy material		all files
Mar 7, 2022	DEFA14A	Extra proxy material		all files
Mar 7, 2022	DEFA14A	Extra proxy material		all files
Mar 7, 2022	DEFA14A	Extra proxy material		all files
Apr 13, 2021	DEFA14A	Extra proxy material		all files
Apr 13, 2021	DEF 14A	Proxy statement	May 25, 2021	all files
May 1, 2020	DEFA14A	Extra proxy material		all files
Apr 8, 2020	DEFA14A	Extra proxy material		all files
Apr 8, 2020	DEF 14A	Proxy statement	May 18, 2020	all files

Show the other 8 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →